Beauty creators and Redditors alike are trying to “hit pan” Meredith Wilshere is a Society and Culture writer at PEOPLE. Her work has previously appeared on PS, Stylecaster, Business Insider, and more ...

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. A ...

This story was originally published by The 19th. In the months leading up to his election, President Donald Trump insisted that he had nothing to do with the far-right vision for his second ...

SINGAPORE, Dec 17 (Reuters) - In a high-security Shenzhen laboratory, Chinese scientists have built what Washington has spent years trying to prevent: a prototype of a machine capable of producing the ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

OpenAI-backed biotech startup Chai Discovery has raised $130 million in a Series B funding round, pushing its valuation to $1.3 billion. With the Series B funding, Chai's total capital raised exceeds ...

Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules. The deal, which values the company ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, today announced its $130 million Series B financing round co ...

Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, today announced its $130 million Series B financing round co-led by Oak HC/FT and General ...